{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:11:07Z","timestamp":1794867067957,"version":"4.9.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00440005"],"award-info":[{"award-number":["RS-2024-00440005"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["MD-PhD\/Medical Scientist Training Program"],"award-info":[{"award-number":["MD-PhD\/Medical Scientist Training Program"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2211760"],"award-info":[{"award-number":["2211760"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2211760"],"award-info":[{"award-number":["2211760"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74384-3","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:14:24Z","timestamp":1781356464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clonal evolution and mutational trajectories of metastatic colorectal cancer shaped by anticancer therapies"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-1851","authenticated-orcid":false,"given":"Won Hee","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-7728","authenticated-orcid":false,"given":"Bun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Yang","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Woon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hwan","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-7961","authenticated-orcid":false,"given":"Sung-Sik","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myong Cheol","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6652-1349","authenticated-orcid":false,"given":"Hail","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5514-4189","authenticated-orcid":false,"given":"Young Seok","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-2247","authenticated-orcid":false,"given":"Hee Jin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-7939","authenticated-orcid":false,"given":"Yongjun","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"74384_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683\u2013691 (2017).","journal-title":"Gut"},{"key":"74384_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"74384_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","volume":"556","author":"SF Roerink","year":"2018","unstructured":"Roerink, S. F. et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature 556, 457\u2013462 (2018).","journal-title":"Nature"},{"key":"74384_CR4","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1158\/1078-0432.CCR-14-2413","volume":"21","author":"T-M Kim","year":"2015","unstructured":"Kim, T.-M. et al. Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity. Clin. Cancer Res. 21, 4461\u20134472 (2015).","journal-title":"Clin. Cancer Res."},{"key":"74384_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05226-0","volume":"9","author":"T Saito","year":"2018","unstructured":"Saito, T. et al. A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer. Nat. Commun. 9, 2884 (2018).","journal-title":"Nat. Commun."},{"key":"74384_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41586-022-05311-x","volume":"611","author":"J Househam","year":"2022","unstructured":"Househam, J. et al. Phenotypic plasticity and genetic control in colorectal cancer evolution. Nature 611, 744\u2013753 (2022).","journal-title":"Nature"},{"key":"74384_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306\u2013313 (2012).","journal-title":"Nature"},{"key":"74384_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613\u2013628 (2017).","journal-title":"Cell"},{"key":"74384_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nm.3915","volume":"21","author":"AA Alizadeh","year":"2015","unstructured":"Alizadeh, A. A. et al. Toward understanding and exploiting tumor heterogeneity. Nat. Med. 21, 846\u2013853 (2015).","journal-title":"Nat. Med."},{"key":"74384_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/gutjnl-2020-323703","volume":"71","author":"H-N Chen","year":"2022","unstructured":"Chen, H.-N. et al. Genomic evolution and diverse models of systemic metastases in colorectal cancer. Gut 71, 322\u2013332 (2022).","journal-title":"Gut"},{"key":"74384_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay9691","volume":"6","author":"HX Dang","year":"2020","unstructured":"Dang, H. X. et al. The clonal evolution of metastatic colorectal cancer. Sci. Adv. 6, eaay9691 (2020).","journal-title":"Sci. Adv."},{"key":"74384_CR12","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41588-019-0525-5","volume":"51","author":"O Pich","year":"2019","unstructured":"Pich, O. et al. The mutational footprints of cancer therapies. Nat. Genet. 51, 1732\u20131740 (2019).","journal-title":"Nat. Genet."},{"key":"74384_CR13","doi-asserted-by":"publisher","unstructured":"Shao, D. D. et al. Advances in single-cell DNA sequencing enable insights into human somatic mosaicism. Nat. Rev. Genet. https:\/\/doi.org\/10.1038\/s41576-025-00832-3 (2025).","DOI":"10.1038\/s41576-025-00832-3"},{"key":"74384_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1926-6","volume":"21","author":"D L\u00e4hnemann","year":"2020","unstructured":"L\u00e4hnemann, D. et al. Eleven grand challenges in single-cell data science. Genome Biol. 21, 31 (2020).","journal-title":"Genome Biol."},{"key":"74384_CR15","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/nprot.2015.088","volume":"10","author":"M Fujii","year":"2015","unstructured":"Fujii, M., Matano, M., Nanki, K. & Sato, T. Efficient genetic engineering of human intestinal organoids using electroporation. Nat. Protoc. 10, 1474\u20131485 (2015).","journal-title":"Nat. Protoc."},{"key":"74384_CR16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883\u2013892 (2012).","journal-title":"N. Engl. J. Med."},{"key":"74384_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","volume":"51","author":"Z Hu","year":"2019","unstructured":"Hu, Z. et al. Quantitative evidence for early metastatic seeding in colorectal cancer. Nat. Genet. 51, 1113\u20131122 (2019).","journal-title":"Nat. Genet."},{"key":"74384_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-021-03786-8","volume":"597","author":"S Park","year":"2021","unstructured":"Park, S. et al. Clonal dynamics in early human embryogenesis inferred from somatic mutation. Nature 597, 393\u2013397 (2021).","journal-title":"Nature"},{"key":"74384_CR19","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1073\/pnas.1525677113","volume":"113","author":"Z-M Zhao","year":"2016","unstructured":"Zhao, Z.-M. et al. Early and multiple origins of metastatic lineages within primary tumors. Proc. Natl. Acad. Sci. USA 113, 2140\u20132145 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74384_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.gastro.2011.11.026","volume":"142","author":"TJ Freeman","year":"2012","unstructured":"Freeman, T. J. et al. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of \u03b2-catenin. Gastroenterology 142, 562\u2013571.e2 (2012).","journal-title":"Gastroenterology"},{"key":"74384_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/path.2539","volume":"218","author":"OR Bandapalli","year":"2009","unstructured":"Bandapalli, O. R. et al. Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases. J. Pathol. 218, 370\u2013379 (2009).","journal-title":"J. Pathol."},{"key":"74384_CR22","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"74384_CR23","doi-asserted-by":"publisher","first-page":"100499","DOI":"10.1016\/j.xgen.2024.100499","volume":"4","author":"J Youk","year":"2024","unstructured":"Youk, J. et al. Quantitative and qualitative mutational impact of ionizing radiation on normal cells. Cell Genom. 4, 100499 (2024).","journal-title":"Cell Genom."},{"key":"74384_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"74384_CR25","first-page":"4571","volume":"10","author":"S Christensen","year":"2019","unstructured":"Christensen, S. et al. 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer. Nat. Commun 10, 4571 (2019).","journal-title":"Commun"},{"key":"74384_CR26","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41588-025-02234-x","volume":"57","author":"E Mitchell","year":"2025","unstructured":"Mitchell, E. et al. The long-term effects of chemotherapy on normal blood cells. Nat. Genet. 57, 1684\u20131694 (2025).","journal-title":"Nat. Genet."},{"key":"74384_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","volume":"4","author":"F Maura","year":"2023","unstructured":"Maura, F. et al. Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells. Blood Cancer Discov. 4, 208\u2013227 (2023).","journal-title":"Blood Cancer Discov."},{"key":"74384_CR28","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 47, 1402\u20131407 (2015).","journal-title":"Nat. Genet."},{"key":"74384_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970\u2013976 (2013).","journal-title":"Nat. Genet."},{"key":"74384_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 (2016).","journal-title":"Nature"},{"key":"74384_CR31","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ng.3934","volume":"49","author":"P Polak","year":"2017","unstructured":"Polak, P. et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat. Genet. 49, 1476\u20131486 (2017).","journal-title":"Nat. Genet."},{"key":"74384_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19406-4","volume":"11","author":"L Nguyen","year":"2020","unstructured":"Nguyen, L. et al. Pan-cancer landscape of homologous recombination deficiency. Nat. Commun. 11, 5584 (2020).","journal-title":"Nat. Commun."},{"key":"74384_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33663-5","volume":"13","author":"E Kuijk","year":"2022","unstructured":"Kuijk, E., Kranenburg, O., Cuppen, E. & Van Hoeck, A. Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue. Nat. Commun. 13, 5915 (2022).","journal-title":"Nat. Commun."},{"key":"74384_CR34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan, T. G. & Croucher, P. I. The dormant cancer cell life cycle. Nat. Rev. Cancer 20, 398\u2013411 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"74384_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","volume":"17","author":"H Clevers","year":"2011","unstructured":"Clevers, H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313\u2013319 (2011).","journal-title":"Nat. Med."},{"key":"74384_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583\u2013594 (2010).","journal-title":"Cell"},{"key":"74384_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/B:BREA.0000004377.12288.3c","volume":"82","author":"GN Naumov","year":"2003","unstructured":"Naumov, G. N. et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res. Treat. 82, 199\u2013206 (2003).","journal-title":"Breast Cancer Res. Treat."},{"key":"74384_CR38","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1172\/JCI96393","volume":"128","author":"I Puig","year":"2018","unstructured":"Puig, I. et al. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. J. Clin. Investig. 128, 3887\u20133905 (2018).","journal-title":"J. Clin. Investig."},{"key":"74384_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522\u2013526 (2012).","journal-title":"Nature"},{"key":"74384_CR40","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ccell.2016.11.002","volume":"30","author":"S Ebinger","year":"2016","unstructured":"Ebinger, S. et al. Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia. Cancer Cell 30, 849\u2013862 (2016).","journal-title":"Cancer Cell"},{"key":"74384_CR41","first-page":"1354","volume":"20","author":"FS Philips","year":"1960","unstructured":"Philips, F. S., Schwartz, H. S. & Sternberg, S. S. Pharmacology of mitomycin C. I. Toxicity and pathologic effects. Cancer Res. 20, 1354\u20131361 (1960).","journal-title":"Cancer Res."},{"key":"74384_CR42","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1158\/1078-0432.CCR-16-0471","volume":"22","author":"DG Stover","year":"2016","unstructured":"Stover, D. G. et al. The role of proliferation in determining response to neoadjuvant chemotherapy in breast cancer: a gene expression-based meta-analysis. Clin. Cancer Res. 22, 6039\u20136050 (2016).","journal-title":"Clin. Cancer Res."},{"key":"74384_CR43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/sj.bjc.6690801","volume":"81","author":"RL Huuhtanen","year":"1999","unstructured":"Huuhtanen, R. L. et al. A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients. Br. J. Cancer 81, 1017\u20131021 (1999).","journal-title":"Br. J. Cancer"},{"key":"74384_CR44","doi-asserted-by":"publisher","first-page":"e26760","DOI":"10.1371\/journal.pone.0026760","volume":"6","author":"RK Kancha","year":"2011","unstructured":"Kancha, R. K. et al. Differential sensitivity of ERBB2 kinase domain mutations towards lapatinib. PLoS One 6, e26760 (2011).","journal-title":"PLoS One"},{"key":"74384_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","volume":"144","author":"PJ Stephens","year":"2011","unstructured":"Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27\u201340 (2011).","journal-title":"Cell"},{"key":"74384_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature14493","volume":"522","author":"C-Z Zhang","year":"2015","unstructured":"Zhang, C.-Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179\u2013184 (2015).","journal-title":"Nature"},{"key":"74384_CR47","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2013.02.023","volume":"152","author":"JO Korbel","year":"2013","unstructured":"Korbel, J. O. & Campbell, P. J. Criteria for inference of chromothripsis in cancer genomes. Cell 152, 1226\u20131236 (2013).","journal-title":"Cell"},{"key":"74384_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","volume":"52","author":"I Cort\u00e9s-Ciriano","year":"2020","unstructured":"Cort\u00e9s-Ciriano, I. et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat. Genet. 52, 331\u2013341 (2020).","journal-title":"Nat. Genet."},{"key":"74384_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-023-06046-z","volume":"617","author":"CH Nam","year":"2023","unstructured":"Nam, C. H. et al. Widespread somatic L1 retrotransposition in normal colorectal epithelium. Nature 617, 540\u2013547 (2023).","journal-title":"Nature"},{"key":"74384_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","unstructured":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"74384_CR51","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.cell.2010.05.021","volume":"141","author":"CR Beck","year":"2010","unstructured":"Beck, C. R. et al. LINE-1 retrotransposition activity in human genomes. Cell 141, 1159\u20131170 (2010).","journal-title":"Cell"},{"key":"74384_CR52","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jmb.2006.01.089","volume":"357","author":"SL Gasior","year":"2006","unstructured":"Gasior, S. L., Wakeman, T. P., Xu, B. & Deininger, P. L. The human LINE-1 retrotransposon creates DNA double-strand breaks. J. Mol. Biol. 357, 1383\u20131393 (2006).","journal-title":"J. Mol. Biol."},{"key":"74384_CR53","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/jnci\/djn359","volume":"100","author":"S Ogino","year":"2008","unstructured":"Ogino, S. et al. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J. Natl. Cancer Inst. 100, 1734\u20131738 (2008).","journal-title":"J. Natl. Cancer Inst."},{"key":"74384_CR54","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1101\/gr.145235.112","volume":"22","author":"S Solyom","year":"2012","unstructured":"Solyom, S. et al. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res 22, 2328\u20132338 (2012).","journal-title":"Genome Res"},{"key":"74384_CR55","first-page":"643","volume":"52","author":"Y Miki","year":"1992","unstructured":"Miki, Y. et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52, 643\u2013645 (1992).","journal-title":"Cancer Res."},{"key":"74384_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11770-0","volume":"10","author":"T Cajuso","year":"2019","unstructured":"Cajuso, T. et al. Retrotransposon insertions can initiate colorectal cancer and are associated with poor survival. Nat. Commun. 10, 4022 (2019).","journal-title":"Nat. Commun."},{"key":"74384_CR57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41588-019-0562-0","volume":"52","author":"B Rodr\u00edguez-Mart\u00edn","year":"2020","unstructured":"Rodr\u00edguez-Mart\u00edn, B. et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat. Genet. 52, 306\u2013319 (2020).","journal-title":"Nat. Genet."},{"key":"74384_CR58","doi-asserted-by":"publisher","first-page":"1251343","DOI":"10.1126\/science.1251343","volume":"345","author":"JMC Tubio","year":"2014","unstructured":"Tubio, J. M. C. et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 345, 1251343 (2014).","journal-title":"Science"},{"key":"74384_CR59","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nm.3870","volume":"21","author":"G Siravegna","year":"2015","unstructured":"Siravegna, G. et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat. Med. 21, 795\u2013801 (2015).","journal-title":"Nat. Med."},{"key":"74384_CR60","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41591-022-01886-0","volume":"28","author":"A Sartore-Bianchi","year":"2022","unstructured":"Sartore-Bianchi, A. et al. Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial. Nat. Med. 28, 1612\u20131618 (2022).","journal-title":"Nat. Med."},{"key":"74384_CR61","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1158\/1078-0432.CCR-17-0232","volume":"23","author":"AR Thierry","year":"2017","unstructured":"Thierry, A. R. et al. Circulating DNA demonstrates convergent evolution and common resistance mechanisms during treatment of colorectal cancer. Clin. Cancer Res. 23, 4578\u20134591 (2017).","journal-title":"Clin. Cancer Res."},{"key":"74384_CR62","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1073\/pnas.1109632108","volume":"108","author":"I Dey-Guha","year":"2011","unstructured":"Dey-Guha, I. et al. Asymmetric cancer cell division regulated by AKT. Proc. Natl. Acad. Sci. USA 108, 12845\u201312850 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74384_CR63","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2012.04.036","volume":"21","author":"CA O\u2019Brien","year":"2012","unstructured":"O\u2019Brien, C. A. et al. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 21, 777\u2013792 (2012).","journal-title":"Cancer Cell"},{"key":"74384_CR64","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2016.01.006","volume":"18","author":"P Bu","year":"2016","unstructured":"Bu, P. et al. A miR-34a-Numb feedforward loop triggered by inflammation regulates asymmetric stem cell division in intestine and colon cancer. Cell Stem Cell 18, 189\u2013202 (2016).","journal-title":"Cell Stem Cell"},{"key":"74384_CR65","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng.363","volume":"41","author":"JA Stamatoyannopoulos","year":"2009","unstructured":"Stamatoyannopoulos, J. A. et al. Human mutation rate associated with DNA replication timing. Nat. Genet. 41, 393\u2013395 (2009).","journal-title":"Nat. Genet."},{"key":"74384_CR66","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature19768","volume":"538","author":"F Blokzijl","year":"2016","unstructured":"Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 538, 260\u2013264 (2016).","journal-title":"Nature"},{"key":"74384_CR67","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-021-03822-7","volume":"597","author":"L Moore","year":"2021","unstructured":"Moore, L. et al. The mutational landscape of human somatic and germline cells. Nature 597, 381\u2013386 (2021).","journal-title":"Nature"},{"key":"74384_CR68","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338\u2013345 (2013).","journal-title":"Nature"},{"key":"74384_CR69","doi-asserted-by":"publisher","first-page":"e41017","DOI":"10.1371\/journal.pone.0041017","volume":"7","author":"K Tabara","year":"2012","unstructured":"Tabara, K. et al. Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cells. PLoS One 7, e41017 (2012).","journal-title":"PLoS One"},{"key":"74384_CR70","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature21356","volume":"543","author":"KM Turner","year":"2017","unstructured":"Turner, K. M. et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543, 122\u2013125 (2017).","journal-title":"Nature"},{"key":"74384_CR71","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/2159-8290.CD-21-1376","volume":"12","author":"E Yi","year":"2022","unstructured":"Yi, E. et al. Live-cell imaging shows uneven segregation of extrachromosomal DNA elements and transcriptionally active extrachromosomal DNA hubs in cancer. Cancer Discov. 12, 468\u2013483 (2022).","journal-title":"Cancer Discov."},{"key":"74384_CR72","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1093\/hmg\/dds240","volume":"21","author":"BL Fogel","year":"2012","unstructured":"Fogel, B. L. et al. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 21, 4171\u20134186 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"74384_CR73","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/ajmg.b.30530","volume":"144B","author":"CL Martin","year":"2007","unstructured":"Martin, C. L. et al. Cytogenetic and molecular characterization of A2BP1\/FOX1 as a candidate gene for autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 869\u2013876 (2007).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"74384_CR74","doi-asserted-by":"crossref","unstructured":"Sengupta, N. et al. Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion. Mol. Cancer 12, 1 (2013).","DOI":"10.1186\/1476-4598-12-1"},{"key":"74384_CR75","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cell.2010.05.020","volume":"141","author":"RC Iskow","year":"2010","unstructured":"Iskow, R. C. et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141, 1253\u20131261 (2010).","journal-title":"Cell"},{"key":"74384_CR76","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1101\/gad.351051.123","volume":"37","author":"C Mendez-Dorantes","year":"2023","unstructured":"Mendez-Dorantes, C. & Burns, K. H. LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities. Genes Dev. 37, 948\u2013967 (2023).","journal-title":"Genes Dev."},{"key":"74384_CR77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41594-020-0374-z","volume":"27","author":"P Mita","year":"2020","unstructured":"Mita, P. et al. BRCA1 and S-phase DNA repair pathways restrict LINE-1 retrotransposition in human cells. Nat. Struct. Mol. Biol. 27, 179\u2013191 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"74384_CR78","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","volume":"14","author":"CJA Punt","year":"2017","unstructured":"Punt, C. J. A., Koopman, M. & Vermeulen, L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat. Rev. Clin. Oncol. 14, 235\u2013246 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74384_CR79","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","volume":"361","author":"SD Markowitz","year":"2009","unstructured":"Markowitz, S. D. & Bertagnolli, M. M. Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449\u20132460 (2009).","journal-title":"N. Engl. J. Med."},{"key":"74384_CR80","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41586-022-05202-1","volume":"611","author":"T Heide","year":"2022","unstructured":"Heide, T. et al. The co-evolution of the genome and epigenome in colorectal cancer. Nature 611, 733\u2013743 (2022).","journal-title":"Nature"},{"key":"74384_CR81","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nprot.2017.111","volume":"13","author":"M Jager","year":"2018","unstructured":"Jager, M. et al. Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures. Nat. Protoc. 13, 59\u201378 (2018).","journal-title":"Nat. Protoc."},{"key":"74384_CR82","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"74384_CR83","doi-asserted-by":"publisher","unstructured":"Benjamin, D. et al. Calling somatic SNVs and Indels with Mutect2. Preprint at https:\/\/doi.org\/10.1101\/861054 (2019).","DOI":"10.1101\/861054"},{"key":"74384_CR84","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"74384_CR85","doi-asserted-by":"crossref","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high-confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinforma. 43, 11.10.1\u201311.10.33 (2013).","journal-title":"Curr. Protoc. Bioinforma."},{"key":"74384_CR86","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"74384_CR87","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2019.05.013","volume":"177","author":"JJ-K Lee","year":"2019","unstructured":"Lee, J. J.-K. et al. Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma. Cell 177, 1842\u20131857.e21 (2019).","journal-title":"Cell"},{"key":"74384_CR88","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"74384_CR89","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1086\/416571","volume":"64","author":"BR Baum","year":"1989","unstructured":"Baum, B. R. PHYLIP: Phylogeny inference package. Version 3.2. Joel Felsenstein. Q. Rev. Biol. 64, 539\u2013541 (1989).","journal-title":"Q. Rev. Biol."},{"key":"74384_CR90","doi-asserted-by":"crossref","unstructured":"Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2, None (2022).","DOI":"10.1016\/j.xgen.2022.100179"},{"key":"74384_CR91","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-022-05072-7","volume":"608","author":"HE Machado","year":"2022","unstructured":"Machado, H. E. et al. Diverse mutational landscapes in human lymphocytes. Nature 608, 724\u2013732 (2022).","journal-title":"Nature"},{"key":"74384_CR92","doi-asserted-by":"publisher","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","volume":"28","author":"T Rausch","year":"2012","unstructured":"Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333\u2013i339 (2012).","journal-title":"Bioinformatics"},{"key":"74384_CR93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"74384_CR94","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1101\/gr.218032.116","volume":"27","author":"EJ Gardner","year":"2017","unstructured":"Gardner, E. J. et al. The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology. Genome Res. 27, 1916\u20131929 (2017).","journal-title":"Genome Res."},{"key":"74384_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24041-8","volume":"12","author":"C Chu","year":"2021","unstructured":"Chu, C. et al. Comprehensive identification of transposable element insertions using multiple sequencing technologies. Nat. Commun. 12, 3836 (2021).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74384-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74384-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74384-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:10:04Z","timestamp":1785517804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74384-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74384"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74384-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.S.J. is a co-founder and major shareholder of Inocras Inc., a San Diego-based precision medicine company. Y.C. is a consulting advisor for IMBdx, Inc, Seoul, Korea. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7509"}}